Yuhan Corp. (000100) - Net Assets

Latest as of December 2025: ₩2.36 Trillion KRW ≈ $1.60 Billion USD

Based on the latest financial reports, Yuhan Corp. (000100) has net assets worth ₩2.36 Trillion KRW (≈ $1.60 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩3.22 Trillion ≈ $2.18 Billion USD) and total liabilities (₩858.64 Billion ≈ $581.89 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Yuhan Corp. (000100) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩2.36 Trillion
% of Total Assets 73.34%
Annual Growth Rate 8.28%
5-Year Change 22.03%
10-Year Change 57.85%
Growth Volatility 4.39

Yuhan Corp. - Net Assets Trend (2000–2025)

This chart illustrates how Yuhan Corp.'s net assets have evolved over time, based on quarterly financial data. See 000100 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Yuhan Corp. (2000–2025)

The table below shows the annual net assets of Yuhan Corp. from 2000 to 2025. For live valuation and market cap data, see how much is Yuhan Corp. worth.

Year Net Assets Change
2025-12-31 ₩2.36 Trillion
≈ $1.60 Billion
+9.84%
2024-12-31 ₩2.15 Trillion
≈ $1.46 Billion
+2.38%
2023-12-31 ₩2.10 Trillion
≈ $1.42 Billion
+4.62%
2022-12-31 ₩2.01 Trillion
≈ $1.36 Billion
+3.71%
2021-12-31 ₩1.94 Trillion
≈ $1.31 Billion
+4.84%
2020-12-31 ₩1.85 Trillion
≈ $1.25 Billion
+11.91%
2019-12-31 ₩1.65 Trillion
≈ $1.12 Billion
-0.11%
2018-12-31 ₩1.65 Trillion
≈ $1.12 Billion
+2.83%
2017-12-31 ₩1.61 Trillion
≈ $1.09 Billion
+7.34%
2016-12-31 ₩1.50 Trillion
≈ $1.01 Billion
+9.72%
2015-12-31 ₩1.36 Trillion
≈ $924.32 Million
+6.90%
2014-12-31 ₩1.28 Trillion
≈ $864.64 Million
+3.88%
2013-12-31 ₩1.23 Trillion
≈ $832.36 Million
+3.37%
2012-12-31 ₩1.19 Trillion
≈ $805.24 Million
+6.40%
2011-12-31 ₩1.12 Trillion
≈ $756.79 Million
+4.10%
2010-12-31 ₩1.07 Trillion
≈ $726.97 Million
+10.85%
2009-12-31 ₩967.71 Billion
≈ $655.80 Million
+12.19%
2008-12-31 ₩862.60 Billion
≈ $584.57 Million
+14.03%
2007-12-31 ₩756.45 Billion
≈ $512.64 Million
+12.50%
2006-12-31 ₩672.40 Billion
≈ $455.68 Million
+13.42%
2005-12-31 ₩592.86 Billion
≈ $401.77 Million
+14.23%
2004-12-31 ₩519.03 Billion
≈ $351.74 Million
+12.33%
2003-12-31 ₩462.04 Billion
≈ $313.12 Million
+13.26%
2002-12-31 ₩407.93 Billion
≈ $276.45 Million
+10.42%
2001-12-31 ₩369.44 Billion
≈ $250.37 Million
+14.17%
2000-12-31 ₩323.58 Billion
≈ $219.29 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Yuhan Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 218847183033000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings ₩2.19 Trillion 94.87%
Other Components ₩118.37 Billion 5.13%
Total Equity ₩2.31 Trillion 100.00%

Yuhan Corp. Competitors by Market Cap

The table below lists competitors of Yuhan Corp. ranked by their market capitalization.

Company Market Cap
Fuyao Glass Industry Group Co. Ltd
F:4FG
$3.90 Billion
L&T Technology Services Limited
NSE:LTTS
$3.91 Billion
Delek Group
TA:DLEKG
$3.91 Billion
AUMOVIO N
XETRA:AMV0
$3.91 Billion
Ventia Services Group Ltd
AU:VNT
$3.90 Billion
Shanghai Xinmei Real Estate Co Ltd Class A
SHG:600732
$3.90 Billion
TIZA Information Industry Corporation Inc
SHE:300209
$3.90 Billion
Carnival Corporation & plc
F:POH1
$3.90 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yuhan Corp.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,100,543,104,230 to 2,306,842,780,630, a change of 206,299,676,400 (9.8%).
  • Net income of 194,079,171,660 contributed positively to equity growth.
  • Dividend payments of 37,481,120,900 reduced retained earnings.
  • Share repurchases of 19,999,943,550 reduced equity.
  • New share issuances of 35,456,020,200 increased equity.
  • Other factors increased equity by 34,245,548,990.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ₩194.08 Billion +8.41%
Dividends Paid ₩37.48 Billion -1.62%
Share Repurchases ₩20.00 Billion -0.87%
Share Issuances ₩35.46 Billion +1.54%
Other Changes ₩34.25 Billion +1.48%
Total Change ₩- 9.82%

Book Value vs Market Value Analysis

This analysis compares Yuhan Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.50x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 3.01x to 2.50x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ₩25980.93 ₩78200.00 x
2018-12-31 ₩26767.73 ₩78200.00 x
2019-12-31 ₩26904.01 ₩78200.00 x
2020-12-31 ₩30079.63 ₩78200.00 x
2021-12-31 ₩28584.38 ₩78200.00 x
2022-12-31 ₩28206.83 ₩78200.00 x
2023-12-31 ₩29195.29 ₩78200.00 x
2024-12-31 ₩28464.98 ₩78200.00 x
2025-12-31 ₩31336.25 ₩78200.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yuhan Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.41%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.88%
  • • Asset Turnover: 0.68x
  • • Equity Multiplier: 1.40x
  • Recent ROE (8.41%) is below the historical average (8.58%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 10.19% 14.75% 0.40x 1.72x ₩617.79 Million
2001 10.54% 14.88% 0.45x 1.58x ₩2.00 Billion
2002 10.79% 15.14% 0.46x 1.55x ₩3.24 Billion
2003 11.12% 16.59% 0.47x 1.43x ₩5.17 Billion
2004 9.81% 14.73% 0.45x 1.47x ₩-996.98 Million
2005 10.31% 15.22% 0.45x 1.52x ₩1.87 Billion
2006 9.70% 15.44% 0.45x 1.40x ₩-2.01 Billion
2007 11.87% 18.20% 0.49x 1.32x ₩14.12 Billion
2008 14.22% 20.07% 0.59x 1.20x ₩36.38 Billion
2009 12.29% 18.39% 0.57x 1.17x ₩22.20 Billion
2010 11.67% 18.87% 0.53x 1.17x ₩17.92 Billion
2011 8.27% 13.60% 0.52x 1.18x ₩-19.27 Billion
2012 6.67% 10.21% 0.55x 1.18x ₩-39.57 Billion
2013 6.91% 8.99% 0.62x 1.23x ₩-37.96 Billion
2014 6.99% 8.76% 0.63x 1.27x ₩-38.47 Billion
2015 9.25% 11.17% 0.60x 1.38x ₩-10.23 Billion
2016 10.77% 12.21% 0.65x 1.37x ₩11.59 Billion
2017 6.81% 7.46% 0.70x 1.31x ₩-50.96 Billion
2018 3.50% 3.78% 0.70x 1.32x ₩-106.69 Billion
2019 2.43% 2.70% 0.70x 1.29x ₩-124.62 Billion
2020 10.48% 11.90% 0.68x 1.30x ₩8.75 Billion
2021 5.32% 6.08% 0.69x 1.28x ₩-90.10 Billion
2022 4.79% 5.36% 0.72x 1.25x ₩-103.44 Billion
2023 6.64% 7.33% 0.66x 1.37x ₩-68.93 Billion
2024 3.37% 3.42% 0.70x 1.40x ₩-139.37 Billion
2025 8.41% 8.88% 0.68x 1.40x ₩-36.61 Billion

Industry Comparison

This section compares Yuhan Corp.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $308,288,097,503
  • Average return on equity (ROE) among peers: 3.35%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yuhan Corp. (000100) ₩2.36 Trillion 10.19% 0.36x $3.90 Billion
Dongwha Pharm.Co.Ltd (000020) $297.40 Billion 3.39% 0.25x $97.49 Million
Yuhan Corp Preferred (000105) $1.65 Trillion 3.48% 0.32x $51.83 Million
Yuyu Pharma (000220) $128.69 Billion -1.72% 0.50x $43.48 Million
Yuyu Pharma Inc (000225) $120.36 Billion -5.97% 0.65x $14.47 Million
Yuyu Pharma Inc (000227) $86.87 Billion 4.63% 0.56x $42.09 Million
Ildong Holdings Co Ltd (000230) $55.81 Billion 8.24% 2.38x $53.57 Million
Samil Pharm (000520) $54.41 Billion 1.08% 0.83x $101.43 Million
Donga Socio Holdings (000640) $266.72 Billion 7.48% 1.59x $367.37 Million
Jw Pharmac (001060) $112.60 Billion 9.51% 2.66x $416.42 Million

About Yuhan Corp.

KO:000100 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$3.90 Billion
₩5.76 Trillion KRW
Market Cap Rank
#4255 Global
#105 in Korea
Share Price
₩78200.00
Change (1 day)
-1.14%
52-Week Range
₩72400.00 - ₩135800.00
All Time High
₩163700.00
About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more